{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:46:32Z","timestamp":1775018792658,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019563","name":"Epilepsiforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019563","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.eplepsyres.2025.107554","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T19:11:52Z","timestamp":1743966712000},"page":"107554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["UGT polymorphisms and epileptic seizure control in pregnant women treated with Lamotrigine"],"prefix":"10.1016","volume":"213","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5488-7992","authenticated-orcid":false,"given":"Nadja Skadk\u00e6r","family":"Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inger","family":"\u00d6hman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Ekstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaiva","family":"Petrenaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.eplepsyres.2025.107554_bib1","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1111\/j.1528-1167.2009.02093.x","article-title":"Utilization of antiepileptic drugs during pregnancy: comparative patterns in 38 countries based on data from the EURAP registry","volume":"50","author":"Battino","year":"2009","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.eplepsyres.2025.107554_bib2","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00228-014-1690-1","article-title":"Correlation of the UGT1A4 gene polymorphism with serum concentration and therapeutic efficacy of lamotrigine in Han Chinese of Northern China","volume":"70","author":"Chang","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.eplepsyres.2025.107554_bib3","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1124\/dmd.109.026609","article-title":"Up-regulation of UDP-glucuronosyltransferase (UGT) 1A4 by 17beta-estradiol: a potential mechanism of increased lamotrigine elimination in pregnancy","volume":"37","author":"Chen","year":"2009","journal-title":"Drug Metab. Dispos.: Biol. Fate Chem."},{"issue":"3","key":"10.1016\/j.eplepsyres.2025.107554_bib4","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1528-1167.2007.00997.x","article-title":"Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial","volume":"48","author":"Christensen","year":"2007","journal-title":"Epilepsia"},{"issue":"OCT","key":"10.1016\/j.eplepsyres.2025.107554_bib5","first-page":"1","article-title":"Structure and protein-protein interactions of human UDP-glucuronosyltransferases","volume":"7","author":"Fujiwara","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.eplepsyres.2025.107554_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1212\/01.wnl.0000195888.51845.80","article-title":"Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry","volume":"66","author":"Group","year":"2006","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.eplepsyres.2025.107554_bib7","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1528-1167.2006.00507.x","article-title":"Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study","volume":"47","author":"Harden","year":"2006","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.eplepsyres.2025.107554_bib8","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1528-1167.2009.02128.x","article-title":"Management issues for women with epilepsy - Focus on pregnancy (an evidence-based review): I. Obstetrical complications and change in seizure frequency: report of the quality standards subcommittee and therapeutics and technology assessment subcommittee o\u2019","volume":"50","author":"Harden","year":"2009","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.eplepsyres.2025.107554_bib9","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1001\/archneur.64.11.1595","article-title":"Epilepsy: accuracy of patient seizure counts","volume":"64","author":"Hoppe","year":"2007","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107554_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/00498250701744633","article-title":"Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination","volume":"38","author":"Jeong","year":"2008","journal-title":"Xenobiotica; fate Foreign Compd. Biol. Syst."},{"issue":"6","key":"10.1016\/j.eplepsyres.2025.107554_bib11","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1517\/17425251003677755","article-title":"Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymes","volume":"6","author":"Jeong","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"2","key":"10.1016\/j.eplepsyres.2025.107554_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/bcpt.13120","article-title":"Meta-analysis of the influence of UGT genetic polymorphisms on lamotrigine concentration","volume":"124","author":"Kim","year":"2019","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"August","key":"10.1016\/j.eplepsyres.2025.107554_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.seizure.2020.07.014","article-title":"Sources of lamotrigine pharmacokinetic variability: a systematic review of population pharmacokinetic analyses","volume":"82","author":"Methaneethorn","year":"2020","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.eplepsyres.2025.107554_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/FPC.0000000000000397","article-title":"PharmGKB summary: lamotrigine pathway, pharmacokinetics and pharmacodynamics","volume":"30","author":"Mitra-Ghosh","year":"2020","journal-title":"Pharm. Genom."},{"issue":"6","key":"10.1016\/j.eplepsyres.2025.107554_bib15","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1528-1167.2007.01471.x","article-title":"Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy","volume":"49","author":"Ohman","year":"2008","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.eplepsyres.2025.107554_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40263-017-0433-0","article-title":"Pregnancy outcomes following in utero exposure to lamotrigine: a systematic review and meta-analysis","volume":"31","author":"Pariente","year":"2017","journal-title":"CNS Drugs"},{"issue":"26","key":"10.1016\/j.eplepsyres.2025.107554_bib17","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1056\/NEJMoa2008663","article-title":"Changes in seizure frequency and antiepileptic therapy during pregnancy","volume":"383","author":"Pennel","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"22 Pt 2","key":"10.1016\/j.eplepsyres.2025.107554_bib18","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1212\/01.wnl.0000289511.20864.2a","article-title":"Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency","volume":"70","author":"Pennell","year":"2008","journal-title":"Neurology"},{"issue":"08","key":"10.1016\/j.eplepsyres.2025.107554_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0074-7742(08)00013-5","article-title":"Chapter 13 antiepileptic drug therapy in pregnancy I. Gestation-induced effects on AED pharmacokinetics\u2019","volume":"83","author":"Pennell","year":"2008","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.eplepsyres.2025.107554_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1212\/01.WNL.0000103286.47129.F8","article-title":"The impact of pregnancy and childbirth on the metabolism of lamotrigine","volume":"62","author":"Pennell","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2025.107554_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.eplepsyres.2018.01.011","article-title":"UGT polymorphisms and lamotrigine clearance during pregnancy","volume":"140","author":"Petrenaite","year":"2018","journal-title":"Epilepsy Res."},{"issue":"ember 2021","key":"10.1016\/j.eplepsyres.2025.107554_bib22","article-title":"Effect of UGT1A4, UGT2B7, UGT2B15, UGT2B17 and ABC1B polymorphisms on lamotrigine metabolism in Danish patients","volume":"182","author":"Petrenaite","year":"2022","journal-title":"Epilepsy Res."},{"issue":"3","key":"10.1016\/j.eplepsyres.2025.107554_bib23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.eplepsyres.2005.06.004","article-title":"Individual changes in lamotrigine plasma concentrations during pregnancy","volume":"65","author":"Petrenaite","year":"2005","journal-title":"Epilepsy Res."},{"issue":"3","key":"10.1016\/j.eplepsyres.2025.107554_bib24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.eplepsyres.2011.02.002","article-title":"Lamotrigine and its N2-glucuronide during pregnancy: the significance of renal clearance and estradiol","volume":"94","author":"Reimers","year":"2011","journal-title":"Epilepsy Res."},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107554_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.yebeh.2013.06.026","article-title":"Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy","volume":"29","author":"Reisinger","year":"2013","journal-title":"Epilepsy Behav."},{"issue":"6","key":"10.1016\/j.eplepsyres.2025.107554_bib26","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/dmd.106.009340","article-title":"In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction","volume":"34","author":"Rowland","year":"2006","journal-title":"Drug Metab. Dispos.: Biol. Fate Chem."},{"issue":"9","key":"10.1016\/j.eplepsyres.2025.107554_bib27","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/j.1528-1167.2009.02166.x","article-title":"Seizure frequency in pregnant women treated with lamotrigine monotherapy","volume":"50","author":"Sabers","year":"2009","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.eplepsyres.2025.107554_bib28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.eplepsyres.2025.107554_bib29","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1111\/j.1528-1167.2012.03439.x","article-title":"Predictors of seizures during pregnancy in women with epilepsy","volume":"53","author":"Thomas","year":"2012","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.eplepsyres.2025.107554_bib30","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/WCO.0000000000000659","article-title":"Teratogenicity of antiepileptic drugs","volume":"32","author":"Tomson","year":"2019","journal-title":"Curr. Opin. Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107554_bib31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1528-1167.2007.01412.x","article-title":"Seizure control in antiepileptic drug-treated pregnancy","volume":"49","author":"Vajda","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107554_bib32","article-title":"Estrogen profile- and pharmacogenetics-based lamotrigine dosing regimen optimization: recommendations for pregnant women with epilepsy","author":"Wang","year":"2021","journal-title":"Pharmacol. Res."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121125000555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121125000555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:34:27Z","timestamp":1762317267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121125000555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":32,"alternative-id":["S0920121125000555"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107554","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"UGT polymorphisms and epileptic seizure control in pregnant women treated with Lamotrigine","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107554","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107554"}}